Suppression of IRAK1 or IRAK4 Catalytic Activity, but Not Type 1 IFN Signaling, Prevents Lupus Nephritis in Mice Expressing a Ubiquitin Binding–Defective Mutant of ABIN1
暂无分享,去创建一个
P. Cohen | J. Arthur | F. Marchesi | S. Nanda | M. López-Peláez | Boehringer Ingelheim | J. Simon | C. Arthur | Astrazeneca | Janssen Glaxosmithkline | Merck-Serono Pharmaceutica | K. Sambit | Prof Philip Nanda | Cohen